MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Genome-wide Survival Analysis Identified Association Between HS1BP3 and APOE loci and Dementia in Parkinson’s disease

    S. Jo, J-H. Oh, J. Lee, S. Son, CO. Sung, SJ. Chung (Seoul, Republic of Korea)

  • Get Ready a mobile phone app a solution for patient engagement/remote management

    R. Mills, M. Gibbs, N. Pavese, D. Ledingham, A. Hussain, A. Jenkins, C. Nicholson (Newcastle, United Kingdom)

  • Giant Aneurysm Causing Parkinsonism and REM Sleep Disorder

    A. Falcone, I. Brum, F. Freua, E. Barbosa, R. Cury, J. Parmera (Sao Paulo, Brazil)

  • Global presence and penetrance of CSF1R-Related disorder

    J. Dulski, M. Baker, S. Banks, M. Bayat, R. Bruffaerts, T. Chmiela, G. Cruz, C. Disserol, K. Fisher, N. Jainy, B. Kálmán, O. Kantarci, D. Maltsev, C. Middleton, G. Novotni, D. Plaseska-Karanfilska, S. Raskin, J. Souza, H. Teive, Z. Wszolek (Jacksonville, USA)

  • Global Trend of Parkinson’s Disease in 38 OECD Countries from 1990-2019: An Insight from the GBD 2019.

    H. Desai, H. Chhayani, N. Brahmbhatt, J. Jobby, B. Desai, M. Lakkimsetti, P. Vemparala (Bhuj, India)

  • GNAO1-related Neurodevelopmental Disorder with Involuntary Movements Inducing a Dyskinetic Status

    M. Silva, P. Lacerda, V. Maciel, K. Massruha, A. Alves, I. Ferreira, I. Brum, A. Santana, M. Sakuma, R. Cury, C. Gusmao (São Paulo, Brazil)

  • Goal Attainment and Ambulation With Increasing Doses of IncobotulinumtoxinA: A Post Hoc Analysis of the TOWER Study

    D. Bensmail, K. Fheodoroff, A. Hanschmann, L. Nicolson, W. Clarke, M. Vacchelli, J. Wissel (Garches, France)

  • GPR30 agonists attenuate haloperidol-induced neurotoxicity in SH-SY5Y cells and adult zebrafish.

    SHU. Upadhayay, PKB. Kumar (Baathinda, India)

  • GRoningen Early-PD Ambroxol Treatment (GREAT) Trial: A randomized, double-blind, placebo-controlled, single center trial with ambroxol in Parkinson patients with a GBA-mutation

    O. Siemeling, S. Slingerland, S. V/d Zee, T. van Laar (Groningen, Netherlands)

  • Gut Microbial Metabolites and Future Risk of Parkinson’s Disease: A Metabolome-wide Association Study

    Y. Zhao, Y. Lai, S. Darweesh, B. Bloem, L. Forsgren, J. Hansen, JM. Huerta, M. Guevara, C. Lill, G. Miller, S. Peters, R. Vermeulen (Utrecht, Netherlands)

  • « Previous Page
  • 1
  • …
  • 80
  • 81
  • 82
  • 83
  • 84
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley